Manufacturing and Analytical Services

  • Manufacturing and Analytical Services
  • You have questions; we have answers.

    Email not displaying correctly? View it in your browser.
    Altasciences
     

    When you need quick answers to your burning questions, simply ask an Altascientist.   

    Chris McEvoy


    How does Altasciences expedite the process for acquiring CITES permits?  
    Watch the video »
    Connect with Chris »

    Scott Boley


    What are the advantages of selecting the miniature swine as a non-rodent model?
    Watch the video »
    Connect with Scott »

    Mathieu Saulnier


    Why is it important to have an in-house team dedicated to bioanalytical equipment?
    Watch the video »
    Connect with Mathieu »

    Lisa Sanford


    Do I need an IND before starting my FIH trial in Canada?
    Watch the video »
    Connect with Lisa »

    Roland Jbeily


    What should sponsors know about Canada’s regulatory requirements for CTA filings?
    Watch the video »
    Connect with Roland »

    Scott Boley


    What factors should sponsors consider when selecting a non-rodent alternative in their nonclinical studies?
    Watch the video »
    Connect with Scott »

    Ben Reed


    What do the recent expansions to Altasciences’ CDMO facility mean for current and future clients?
    Watch the video »
    Connect with Ben »

    Dennis DiBiagio


    How does Altasciences’ manufacturing site support the development of drugs that treat CNS disorders?
    Watch the video »
    Connect with Dennis »

    Submit a question
    See full video series

    Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.
     

    Altasciences has been recognized as a 2023 CRO Leadership Award Champion in the Capabilities category, as voted by you in ISR’s annual CRO Quality Benchmarking survey.

      



    ​​​​​​

    LET'S STAY CONNECTED!
     

    LinkedInLinkedIn   YouTubeYouTube   BlogBlog
     
    OUR SERVICES
    Preclinical   —   Clinical   —   Manufacturing and Analytical
    Bioanalysis   —   Research Support
    Copyright © {{Current_Year}}, Altasciences, All rights reserved.

    Our mailing address is:

    Altasciences
    575 Armand Frappier
    Laval, H7V 4B3
    Canada


    You are receiving this email because you are a friend of Altasciences, or have opted in via our website or while speaking to us at a recent event.

    Want to change how you receive these emails?
    You can update your preferences or unsubscribe from this list.


     

    VIRTUAL TOUR: Discover our In-House R&D and Formulation Laboratories

     

    Enhance Your Outcomes With Our Analytical Services

    Altasciences’ in-house R&D and formulation laboratories offer an extensive array of analytical solutions to support sponsors’ drug development and manufacturing programs.

    Our services include:

    •    HPLC/UPLC testing
    •    Method development and validation
    •    ICH stability storage and testing
    •    APIs, excipients, and packaging components
    •    Drug product release testing, including controlled substances

    Take a virtual tour of our laboratories, or consult with one of our experts to discuss your study needs.
     

    Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.

    Insights―Successful Manufacturing of Clinical Trial Supply

     

    Discover the Secrets to Clinical Trial Success

    As an integrated CRO/CDMO, Altasciences’ Clinical and CDMO teams work in tandem to manufacture the optimal dosage in preparation for first-in-human clinical trials.

    In this latest podcast, our formulation and pharmacy experts share their secrets for successfully completing clinical trials and resolving issues that could impact your drug development program’s timeline.

    LISTEN NOW!

     

    Speak with our experts for all your pharmaceutical development and manufacturing needs in support of your upcoming clinical trials.

    Related resources that may interest you:

    •    Webpage: Altasciences’ Manufacturing and Analytical Services
    •    Scientific Journal: Maximizing Formulations for First-in-Human Trials 
    •    Infographic: Benefits of Using Liquid-Filled Capsules in Clinical Trials


    Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.

    Custom Dosage Form Solutions for All Study Phases

     

    Versatile Dosage Forms―From Formulation to Market

    For decades now, our U.S.-based cGMP manufacturing and analytical testing facility has been moving molecules from benchtop to market. Following formulation, we manufacture the dosage form you require for your nonclinical and clinical studies, as well as your commercial batches.

    Dosage forms we manufacture and package include tablets, liquid-filled hard-shell capsules, powder-filled capsules, over-encapsulation, injectables, liquids and suspensions, creams, and gels.

    Consult with our experts to discover how we can fulfill your manufacturing needs.


    Resources that may interest you: 

    •    Infographic: Benefits of Liquid-Filled Capsules as a Dosage Form
    •    Quick Chat: What Our Facility Expansions Mean For You
    •    Webpage: Altasciences’ Comprehensive Drug Manufacturing and Analytical Testing Services

     

    A Game-Changer for Poorly Soluble APIs

     

    A Game-Changer for Poorly Soluble APIs

    Fact: Over 70% of active pharmaceutical ingredients (APIs) entering the drug development pipeline are poorly water-soluble and thus, insufficiently bioavailable.

    Nanomilling is one of the most effective proven techniques used to resolve solubility challenges and can be applied to almost any API with water solubility below 200 μg/mL. Benefits include particle size reduction, ease of scalability, reduced fed/fasted variability in both liquid and solid dosage forms, faster onset of therapeutic action, and low excipient side effects.

    Learn more about our extensive expertise in nanomilling with a broad range of APIs, or speak with one of our formulation experts to find out how we can help.
     
    Related resources that may interest you:

    •    Webpage: Global CDMO for Drug Manufacturing and Analytical Testing Services
    •    Scientific Journal: Nanomilling for Better Solubility and Enhanced Bioavailbility
    •    Webinar: The Development of Nanosuspension Formulations

    Our Role in Treating Mental Health and CNS Disorders

     

    Leading Partner in CNS Drug Development and Manufacturing

    In honor of Mental Health Awareness month, we asked our CDMO Vice President and Scientific Advisor, Dennis DiBiagio, what specific expertise is required to manufacture drugs that treat central nervous system (CNS) disorders, including mental disabilities.

    Watch our latest clip of Ask an Altascientist.

                                             Video Thumbnail

    Speak with Dennis today about the unique and most advantageous reason drug sponsors choose to partner with us for their CNS drug development!
     
    SEND DENNIS A MESSAGE
     

    You may also be interested in these related resources:

    •    Webpage: Global CDMO for Manufacturing and Analytical Services
    •    Interview: Manufacturing of Highly Potent APIs and Controlled Substances
    •    Podcast: Key Considerations as You Move From Discovery to Preclinical to Clinical

    Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.
     

    Scientific Journal on the Intricacies of CNS Drug Development

    In this issue of The Altascientist, we detail the complexities of central nervous system (CNS) drug development programs. In addition, we share how partnering with an integrated CRO/CDMO can reduce your timelines by up to 40% as your compound advances through each study phase. 

    Topics covered include: 

    • Preclinical safety and toxicity testing 
    • Formulation and manufacturing for nonclinical and clinical studies 
    • Maximizing early phase clinical trials 
    • Bioanalytical considerations 

    DOWNLOAD NOW 

    Questions? Consult with our experts and tell us how we can support your program.

    Related resources that may interest you

    Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.

    Get Quicker Clinical Trial Data

    Accelerate Your Clinical Trials with Liquid-Filled Capsules

    Liquid-filled, two-piece capsules offer countless advantages over other solid dosage forms―ease of scalability and manufacturing, faster absorption, simpler packaging, and higher product stability, to name a few.

    They are also the recommended dosage form for insoluble or highly potent APIs, and are known to accelerate product development because they can be made with fewer excipients than other solid dosage forms, such as tablets.

    Discover the full benefits of using liquid-filled capsules in your clinical trials, or view this infographic for a quick tutorial.

    The Benefits of LFCs

    Related Resources:

    • Webpage: Contract Manufacturing and Analytical Solutions
    • eBook: Applications of Liquid-Filled Capsules in Drug Development
    • Webinar: Manufacturing Solutions Using Liquid-Filled Capsules

    Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.

    Avoid These Mistakes During Formulation for Nonclinical Testing

    Improve Your Odds of Success

    Formulation development is a critical step that ensures the drug product is produced safely and effectively for use in nonclinical testing and, eventually, in clinical trials. Solubility, stability, route of administration, and dosage frequency are some of the factors assessed during formulation development.

    In this podcast, our scientific experts discuss the everyday challenges encountered in formulation development for nonclinical testing, and tips to avoid or mitigate them to facilitate your IND application.



    Do you need your API formulated and manufactured for nonclinical testing? Contact us today to get started!

    Related Resources:

    • Webpage: Contract Manufacturing and Analytical Solutions
    • Interview: Complex and Customized Formulation Development
    • Podcast: Key Considerations as You Move From Discovery to Preclinical to Clinical

    Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.

    Subscribe to Manufacturing and Analytical Services